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The incidence of melanoma has been steadily increasing worldwide, at an average rate of 4 to 6% per year (Ries et a l } 1991) and has been noted as rising faster than all other types of cancer. It now constitutes around 3% of all malignant diseases. Adults in all age groups are affected, with a reported world wide average age at diagnosis of 48 years (Balch, 1992) . Children are rarely affected. Despite this rarity, it is imperative that clinicians be aware that melanoma does occur in child hood. However, there is very little information available on the clinico-pathologic variations, and the prognostic parameters of malignant melanoma in children. Difficulties in investigation of this subject are multiple: there are few series with adequate follow-up; criteria for inclusion in the published studies are heterogeneous; the histologic criteria established for the recognition of melanoma in adults are not absolutely appli cable to those of children; and, finally, the histo-prognostic parameters used in adults have not been validated in children. Thus, many authors have pointed out the necessity of a large multicentre study on melanoma in children.
In order to provide criteria which may be of help in the diagnosis and treatment of childhood melanoma, we have conducted a multicenter study in institutions that provide members of the EORTC-Melanoma Cooperative Group. In the present paper, we examine the clinico-pathological fea tures of 102 cases referred to our institutions as childhood melanoma between 1961 and 1994.
MATERIAL AND METHODS

Design
Cases were all the patients for whom a diagnosis of cutane ous melanoma had been made before their 17th birthday and from whom a representative slide of the lesion was available in one of the collaborating centers. This included cases with congenital nevi and xeroderma pigmentosum. The cases were collected during the time period 1961-1994, which represents the range of earliest and latest reports. The following institu tions constituted the study group: Institut Gustave-Roussy, Villejuif, France (34 cases); University Hospital, Nijmegen, The Netherlands (31 cases); Institut Jules Bordet, Brussels, Belgium (16 cases); Kantonsspital, Münsterlingen, Switzer land (11 cases); Hôpital Henri-Mondor, Créteil, France (9 cases); Hautklinik der Universität, Würzburg, Germany (3 cases); Centre Léon-Bérard, Lyon, France (2 cases); and Universiteit Gent, Gent, Belgium (1 case). The Dutch cases came from a national registry representing complete popula tion coverage. The other slides were from children followed in the center or referred to the center due to difficulty in making a diagnosis. About 50 cases would have been eligible for inclu sion, but had to be excluded because no slides were available for review.
Clinical param eters
Clinical variables included date of birth, age at diagnosis, sex, localization, clinical diagnosis, associated cutaneous melanocytic lesion, treatment, date of first recurrence, date of last follow-up information, and vital status. Family history of melanoma was defined as histologically confirmed melanoma diagnosed in 2 family members. The stage at diagnosis was classified according to Schultz and Mastrangelo (1989) . Apart from the family history of disease in patients followed at the Institut Gustave-Roussy, which was collected directly from patients by a research team, all these data were collected from routine clinical records.
Pathologic param eters
The slides were reviewed by a panel of 7 pathologists (A.S., D.R., T.H., N.R., J.W., C.B., M.P.). All the panel members reviewed all the slides. In the great majority of cases, panel members were not involved in making the original diagnoses. This review was made with no knowledge of the clinical outcome, and resulted in classification into 2 groups: a group of lesions initially diagnosed as melanoma and reclassified as such by the reviewing group, and a group of lesions initially diagnosed as melanoma but reclassified as nevus. Panel mem bers were aware of how the other reviewers scored the slides.
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S? ATX ET AL. However, when responses were discordant (30 cases), the diagnosis was made by consensus. The lesions confirmed as melanoma were classified according to the international classi fication of melanoma (McGovern et a l , 1973) , and then to Clark's anatomical levels. The tumor thickness was measured by micrometer according to Breslow. For all lesions, the other pathological features evaluated included size, mitotic rate per 10 fields using a x40 objective (HPF), location of mitoses, presence and size of ulceration, features of inflammatory regression, evidence and nature of associated lesion, symmetry of lesion, evidence and location of ascension into the epider mis, demarcation of the borders, maturation, location and type of melanin, cellular appearance, type of cells, nuclear abnor malities, inflammatory infiltrate and microscopic details of excision margins. The cases reviewed included 13 reported earlier (cases 1-13; Lartigau e t a l , 1995).
Analysis
All cases were entered into a computerized data base, using the EPI INFO 6 software (Centers for Disease Control and Prevention, USA). Comparisons of melanoma and nevi pa tients used Chi-squared tests for qualitative variables and the Wilcoxon 2-sample test for quantitative variables. Comparison of the age distribution for the different tumoral sites used the Kruskal-Wallis test. Overall survival was assessed using Kaplan-Meier estimates. The univariate analysis of risk factors for metastasis or death used the log-rank test (Peto and Peto, 1972) . Multivariate survival analysis was performed with a Cox proportional-hazard model (Cox, 1972) .
RESULTS
The clinical and pathologic findings of the 102 cases histologi cally reviewed are presented in Tables I and II . On the basis of this review, 60 lesions were classified as melanoma. Forty-two lesions initially diagnosed as melanoma were reclassified as Spitz nevus (6 cases), atypical Spitz nevus (5 cases), Reed nevus (11 cases), congenital-type nevus (4 cases), halo nevus (2 cases), deep-penetrating nevus (1 case) and other types of nevus (13 cases). Table III compares the histologic features of the lesions reviewed as melanoma with those reviewed as nevus. Con firmed melanomas were larger (i.e., > 1 mm), and more often presented ulceration, high mitotic activity (>5 mitoses/10 HPF), mitoses in the lower third of the lesion, epitheloid melanocytes, asymmetry, lateral borders not well demarcated, lack of maturation, dusty melanin, and marked nuclear poly morphism. A predominance of spindle cells indicated a nevus; thus, 31 lesions (74%) initially diagnosed as melanoma but reviewed as nevus contained spindle cells. Thirty-five (59%) melanomas were superlicial-spreading melanomas (SSM), dis playing a prominent pagetoid intra-epidermal component. Nine (16%) melanomas were nodular (NM). Two cases (cases 6 and 10), involving the heel in Caucasian patients, had a lentiginous intra-epidermal component. Another case (case 55), diagnosed in a patient with x ero d em a pigm entosum , was similar to lentigo malignant melanomas diagnosed in elderly patients. Six cases were characterized by a prominent compo nent of monomorphous small cells, containing basophilic round nuclei, reminiscent to those of a lymphoma or a melanocytic nevus (Fig. 1) . Five cases were Spitz-nevus vari ants. These tumors were composed of epitheloid or spindle cells resembling the cells in Spitz nevi. There were only few mitoses (1 to 2 mitoses/10 HPF), but they were located in the deep part of the lesion, and the cells exhibited marked nuclear atypia (Fig. 2) . Three melanomas resembled deep-penetrating nevus by their extension into the deep dermis or fat and by a large nevic cell type with pigment synthesis through the full thickness of the lesion (Fig. 3) . In these lesions, mitoses were frequent (8 to 30 mitoses/10 HPF) and deeply situated. In 59 melanomas, the mean thickness was 3.00 mm, with a range of 0.20 mm to 15 mm; 39 cases (66%) were thicker than 1.50 mm.
Table IV summarizes the clinical features of the melanomas in comparison with those of the lesions reclassified as nevus. The patients ranged in age from 1 to 16 years, with a mean age for patients with melanoma of 10.4 years, not significantly different from those of patients with nevus. In the 2 groups, gender was equally distributed. There was no significant correlation between the localization and the final diagnosis. Age at diagnosis varied with site: patients with head and neck melanoma were the youngest, patients with trunk and lower-Iimb melanoma were the oldest, and those with upper-limb melanoma were at an intermediate age ( p < 0.001). Eighteen patients (30%) with melanoma had an associated condition. These included xeroderma pigmentosum in 5 cases, a family history of melanoma in 2 cases. In 11 cases (18%) the melanoma arose on a nevus, of congenital type in 4 cases (6%). Another patient (case 3) had a personal history of rhabdomyo sarcoma diagnosed at 5 years of age and treated by surgical excision, chemotherapy (6 courses of vincristine, actinomycin and cyclophosphamide), and external radiotherapy (45 Gy). The melanoma appeared 2 years later on the border of the irradiated area. Fifty-two patients (88%) with melanoma had localized disease (Stage I) at presentation, while 6 patients (10%) had regional metastases (Stage II), and one patient had disseminated disease (Stage III). Nine patients (cases 1, 5, 10, 12, 14, 16, 35, 38, 50) received systemic chemotherapy for metastatic disease. One patient (case 4) received adjuvant chemotherapy at the time of diagnosis. A regional lymph-node metastasis appeared 9 months after diagnosis. One patient (case 76), with a lesion reviewed as nevus, had received '.K 4-' • ■ ' I ■ : F ig u r e 1 -Small-cell melanoma. The dermis contains areas of small nevus-like cells that are monomorphous, with lack of maturation (case 18, H&E, scale bar, 0.8 mm). Insert; Some nuclei are hyperchromatic, while mitoses are present in the deep part of the lesion.
immunotherapy. This patient was in good health 30 months after diagnosis.
Among 60 patients with melanoma, follow-up ranged from 0 to 27 years (mean: 5 years). Nine patients had no follow-up. Forty-one patients (68%) were followed up for more than one year. Twenty (39%) of the 51 patients with follow-up have had metastases. Seven of these died of their disease, including one patient (case 11) who died with multiple metastases 14 years after the diagnosis, 3 were alive with melanoma, and 10 were free of disease after 44 to 328 months to follow-up (mean: 115 months). Thirty-one patients remained free of disease, with follow-up duration of 5 years or more for 20 patients. The 5-year survival rate is 84%. The only statistically significant parameter associated with the development of metastases or fatal outcome was a thickness of more than 2.00 mm (p < 0.001). At 5 years, disease-free rates were 81% [confi dence interval (Cl), 71-91%] for patients with melanoma up to 2.00 mm thick, and 28% (Cl, 18-38%) for those with mela noma more than 2.00 mm thick. There was no difference in prognosis among lesions of Clark's level II or III and those of Clark's level IV or V ( p = 0.15), or between males and females ( p = 0.09). A multivariate-suivival analysis confirmed these results (Table V) . There was no recurrence in 30 patients with a benign lesion who were followed up for one month to 11 years (mean: 49 months). Twelve patients with nevus had no follow-up. DISCUSSION Melanoma is rare in childhood, less than one percent of melanomas occurring in patients under the age of 17 years (Urist and Hynds Karnell, 1994) . In Queensland, the ageadjusted incidence for children aged 0 to 14 was nearly 10/million children/year, compared with age-adjusted inci dence rates of 666/million in adult males and 564/million in adult females (Whiteman et a i , 1995) . Because of this rarity, only a limited number of cases have been reported and, in several of those series, the lesions have not been subjected to histopathologic review. Moreover, follow-up is often missing. This report presents the results of a retrospective multicenter study of 102 lesions originally diagnosed as cutaneous mela noma conducted among 5 Western European countries.
Mackie et a l (1991), in a study of 95 patients below 30 years of age have shown a survival advantage for females. They suggested a phenotypic rather than an acquired characteristic. The fact that, in the present series of patients aged 0 to 16, melanomas in males carry the same prognosis as in females suggests that the prognostic value of gender appears later in life. The site distribution of the melanomas was similar to those of the nevi, whatever the gender, the lower limb being the most frequent site. Genetic and congenital predisposition to the development of melanoma include xeroderma pigmento sum, family history of melanoma, congenital nevi and dysplastic nevi. In addition, immunosuppression can be considered as such. Five patients in our series had xeroderma pigmentosum; they were less than 10 years old and developed melanoma on the head; 3 of them had also spino-cellular carcinomas at diagnosis, leading to death in one patient. Two patients with melanoma came from melanoma-prone families. Novakovic et a l (1995), in studying 23 melanoma-prone families, showed that a family history of melanoma and the presence of dysplastic nevi identify children with a high risk of melanoma developing at an early age. Among 125 patients below 20 years of age at the time of first clinical evaluation, they observed 5 invasive melanomas in 4 patients diagnosed before the age of 17 years, all of them occurring within a precursor nevus. Although it has been stated that one third of prepubertal melanomas arose in large congenital nevi, this notion has been disputed. In our series, only 4 melanomas arose in a congenital nevus; they were diagnosed at one year of age in 2 patients, at 6 years of age in another, and at 13 years of age in the fourth patient. If the frequency of malignant transformation in congenital nevi is presumed to be less than 5% (Kopf et a l, 1979) , half the cases of melanoma within congenital nevi occur in the first decade of life (Ruiz-Maldonado et a l , 1992) . Thus, when prophylactic removal of congenital nevi is decided, it should be done in early life.
The histopathologic diagnosis of melanoma in children is difficult because of the occurrence of histologic simulators of melanoma such as atypical Spitz tumors and atypical areas developing in congenital nevi. The fact that 40% of lesions initially diagnosed as melanoma were reclassified after review as nevus in our series illustrates the difficulty in diagnosing childhood melanoma. Nevertheless, most studies have empha sized the necessity for earlier recognition of melanoma in children and adolescents (Ceballos et a l , 1995) . This is supported in the present series by the observation that 66% of the melanomas were thicker than 1.5 mm. Since the initial description of the Spitz nevus by Spitz (1948) , the distinction between melanomas and Spitz nevi is still one of the most difficult problems in pathology and may lead in quite a few instances to over-diagnosis of melanoma. On the other hand, 9 melanomas associated with death or widespread metastases and initially diagnosed as Spitz nevi have been reported in the literature (Spitz, 1948; Boddie et a l , 1978; Peters and Goellner, 1986; Crotty et a l , 1992; Mehregan and Mehregan, 1993; Tate et a l, 1993; Barnhill et a l , 1995) . The case reported by Barnhill et a l (1'995) was fairly symmetric and had a low mitotic rate. In the present study, 5 patients had Spitz-like melanoma (cases 1, 2, 12, 52, 59). Two of them developed metastases, leading to death in one patient. All of these lesions were characterized by deep mitoses, marked nuclear atypia and high cellularity. Despite their particular pathologic presen tation and the difficulty in distinguishing them from Spitz nevi, more studies with adequate follow-up are needed before placing these lesions in a separate category. Eleven lesions were reclassified as pigmented spindle-cell Reed nevi, because of the presence of nests of large melanin-containing spindle cells in a heavily pigmented sharply demarcated lesion contain ing occasional mitoses. It is noteworthy that 31 lesions initially diagnosed as melanoma but after review classified as nevus contained a predominance of spindle cells. None of these lesions has recurred. As noted by Smith (1987), spindle-cell nevi represent a clinico-pathologic spectrum which is too often misdiagnosed as melanoma. In several studies, it was suggested that tumor thickness was of less prognostic value in children than in adults. Our data do not support this viewpoint, since tumor thickness appeared to be the best prognostic indicator. JOriginalIy diagnosed as melanoma, but after review classified as nevus.-2Relative tumor density = proportion of tumors occur ring at site divided by proportion of total body-surface area occupied by that site.
In conclusion, the diagnosis of melanoma in children has to be assessed extremely carefully, since some benign lesions, i.e., atypical Spitz nevi and pigmented spindle-cell nevi, have very similar histologic features. On the other hand, since tumor thickness is the prevailing prognostic parameter, early diagno sis of melanoma in this population of patients also should be made. It has been suggested in literature that melanoma in children is associated with a poorer prognosis than in adults (Mehregan and Mehregan, 1993) . The 5-year survival rate observed in our study is 84%, which is higher than that in adult patients when matched for thickness (Balch, 1992) . However, prospective studies of melanoma in children and related atypical nevi need to be carried out in order to give consistent epidemiological data and to increase recognition of relevant diagnostic features, both by clinicians and pathologists. For this purpose, we propose to set up in Europe a central registry of melanomas in children, under the auspices of the EORTC Melanoma Cooperative Group.
